What's breaking now, across thousands of outlets.
(MedPage Today) -- The FDA expanded the indications for the B-cell depleter obinutuzumab (Gazyva) to include idiopathic nephrotic syndrome, the agency announced on Friday, the first new option for the rare kidney disease in more than half a century...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.
New research supports the idea that the moon once had its own internal magnetic field just as Earth does today.
The United States rejected a nonbinding United Nations declaration pledging international collaboration to improve pandemic preparedness and prevention, joining the European Union in objecting to the…
"We identified a very understudied brain region and then found the first function for that brain region."
RNA vaccines and other nucleic acid therapeutics are typically packaged within fatty molecules known as lipid nanoparticles (LNPs). MIT researchers have now developed a way to produce these particles much more quickly and with more precise control over their size and shape.
When bullfrog brains run low on energy, they can make their own emergency fuel. The finding could have implications for human health.
A new study offers fresh hope that some forms of vision loss, once thought to be permanent, might one day be recoverable.
